Amplification of the BCAS2 gene at chromosome 1p13.3-21 in human primary breast cancer.

[1]  T. Ried,et al.  Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu , 2002, Oncogene.

[2]  M. Pike,et al.  Germ-line HER-2 variant and breast cancer risk by stage of disease. , 2001, Cancer research.

[3]  M. Abba,et al.  c-myc gene amplification detected in preinvasive intraepithelial cervical lesions , 2001, International Journal of Gynecologic Cancer.

[4]  Y. Chen,et al.  Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. , 2000, Cancer research.

[5]  R. Neumann,et al.  Amplification of the mdr1-gene is uncommon in recurrent ovarian carcinomas. , 1999, Cancer letters.

[6]  K. Yamaguchi,et al.  Identification of a novel gene, DAM1, amplified at chromosome 1p13.3-21 region in human breast cancer cell lines. , 1999, Cancer letters.

[7]  I. Bièche,et al.  Deletion mapping of chromosomal region 1p32‐pter in primary breast cancer , 1999, Genes, chromosomes & cancer.

[8]  Juri Rappsilber,et al.  Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex , 1998, Nature Genetics.

[9]  C. Guthrie,et al.  Mechanical Devices of the Spliceosome: Motors, Clocks, Springs, and Things , 1998, Cell.

[10]  M. Schwab,et al.  Genomic instability in Ip and human malignancies , 1996, Genes, chromosomes & cancer.

[11]  A. Krämer,et al.  The structure and function of proteins involved in mammalian pre-mRNA splicing. , 1996, Annual review of biochemistry.

[12]  J. Foekens,et al.  Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment. , 1995, Gene.

[13]  J. Varley,et al.  Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast. , 1995, Oncogene.

[14]  C. Croce,et al.  Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer. , 1995, Cancer research.

[15]  Phillip A. Sharp,et al.  Split genes and RNA splicing , 1994, Cell.

[16]  D. Birnbaum,et al.  DNA amplification at 11q13 in human cancer: from complexity to perplexity. , 1992, Mutation research.

[17]  M. Fernö,et al.  ERBB2 amplification in breast cancer with a high rate of proliferation. , 1991, Oncogene.

[18]  E. Mitchell,et al.  1P13 is the most frequently involved band in structural chromosomal rearrangements in human breast cancer , 1990, Genes, chromosomes & cancer.

[19]  G. Merlo,et al.  Frequent alteration of the DF3 tumor-associated antigen gene in primary human breast carcinomas. , 1989, Cancer research.

[20]  M. Genuardi,et al.  Distal deletion of chromosome Ip in ductal carcinoma of the breast. , 1989, American journal of human genetics.

[21]  B. Ganem.  RNA world , 1987, Nature.